Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Scavenger hunts and happy hours: 5 featured Techweek events
With Techweek Kansas City quickly approaching and expecting more attendees than ever, it’s time to start pulling out calendars to decide events to hit up. Startland picked a few events off the list that stand to wet the whistle of any techie or entrepreneur. The full schedule is here, which Techweek is expected to expand…
Silicon Valley vet Jason Anderson makes a game out of data collection
As a 4-year-old, Jason Anderson was captivated by the Atari classic Pong. He gawked at the game for hours after his dad brought one home in 1978. Four years later, he was so inspired by Pong that he decided to create his own game — a text adventure on the family’s Timex Sinclair 1000. Anderson…
Compute Midwest named top national tech conference
Consistently attracting futurists and tech leaders from around the U.S., Compute Midwest recently was named a national tech conference that shouldn’t be overlooked. Inc. Magazine included the annual, Kansas City-based conference on its “Top Tech Conferences You Can’t Miss This Fall” list, noting the event’s traditionally strong lineup of speakers. Presented by the Disruption institute,…
Dozens of skyrocketing KC firms break into the Inc. 5000
Kansas City held its own on Inc. Magazine’s annual ranking of the nation’s fastest-growing, private companies. The Wednesday unveiling of the Inc. 5000 featured 44 metro firms — including several area tech firms, like k12itc and Rhythm Engineering. K12itc, which in January made Startland’s 2016 top 10 startups to watch, delivers cloud-based IT services to…